Pediatric Vaccine Market: Size, Share, Trends & Forecast (2024-2029) 

The market report presents a thorough analysis segmented by Vaccine Type (Monovalent, Multivalent); by Application (Pneumococcal Disease, Influenza, Measles, Mumps and Rubella, Others); by Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa).

Outlook 

• The pediatric vaccine market is estimated to be at USD 23,667.31 Mn in 2025 and is anticipated to reach USD 32,254.11 Mn in 2030. 

• The pediatric vaccine market is registering a CAGR of 6.39% during the forecast period 2025-2030. 

• The pediatric vaccine market is experiencing robust growth, driven by rising awareness of immunization’s role in preventing childhood diseases and growing investment in vaccine research and development. Advanced technologies, such as mRNA and intranasal vaccines, are expanding options for safer and more effective pediatric vaccines. However, challenges like high immunization costs and limited healthcare infrastructure in low- and middle-income countries (LMICs) remain significant barriers. The market’s future relies on innovations that address these challenges, which aim to improve global vaccine accessibility and coverage for children. 

Request a free sample. 

Ecosystem 

• The participants in the global pediatric vaccine industry are always developing their strategies to preserve a competitive advantage. 

• Partnerships between pharmaceutical companies, governments, and organizations like Gavi and the World Health Organization (WHO) facilitate vaccine accessibility and affordability, helping large companies expand into underserved regions and strengthening their market presence. 

• Several important entities in the pediatric vaccine market include Sanofi; Merck & Co., Inc.; Pfizer Inc.; Sinovac Biotech Ltd.; AstraZeneca Plc; and others. 

Ask for customization. 

Findings 

Attributes	Values
Historical Period	2019-2023
Base Year	2024
Forecast Period	2025-2030
Market Size (2025)	USD 23,667.31 Mn
Market Size (2030)	USD 32,254.11 Mn
Growth Rate	6.39% CAGR from 2025 to 2030
Key Segments	Vaccine Type (Monovalent, Multivalent); Application (Pneumococcal Disease, Influenza, Measles, Mumps and Rubella, Others); Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa)
Key Vendors	Sanofi; Merck & Co., Inc.; Pfizer Inc.; Sinovac Biotech Ltd.; AstraZeneca Plc
Key Countries	The US; Canada; Mexico; Brazil; Argentina; Colombia; China; India; Japan; South Korea; The UK; Germany; Belgium; France; Turkey; UAE; Saudi Arabia; Egypt; South Africa
Largest Market	North America

Get a free quote. 

Trends  

• mRNA Vaccine Advancements: mRNA vaccines, initially accelerated by COVID-19, are now expanding into pediatric use for diseases like influenza and RSV. Companies are adapting dosages and formulations to ensure efficacy and safety for younger age groups while also exploring multi-disease formulations in a single dose. mRNA-1230, developed by Moderna, is a multi-disease vaccine that aims to protect against multiple respiratory illnesses in a single shot, especially tailored for younger age groups. 

• Innovation in Needle-Free Delivery Systems: Innovations in needle-free vaccine delivery, including microneedle patches and jet injectors, are gaining traction for pediatric vaccines to minimize pain and anxiety in children. Microneedle patches are shown to provide accurate dosages while being pain-free and easier to administer in non-clinical settings. 

• Development of Intranasal Vaccines: Intranasal vaccines are being developed for diseases like influenza and RSV, which offer a painless alternative that is also easy to administer. These vaccines are specifically designed for young children to reduce distress and are found to trigger strong mucosal immunity, which can be more effective for respiratory infections. 

Speak to analyst. 

Catalysts 

• Rising Burden of Chronic Diseases with Immunization Importance: The increasing prevalence of chronic diseases and autoimmune conditions among children has amplified the need for early and effective immunization. Chronic conditions such as asthma, diabetes, and congenital disorders often compromise immunity, which makes vaccinated protection critical to prevent severe infections. This focus on immunization for vulnerable groups encourages the development of specialized vaccines, particularly for pediatric populations. 

• Increased Awareness of Immunization and Vaccine Benefits: Awareness campaigns by health organizations on the importance of pediatric immunization are significantly driving vaccine adoption. With targeted educational programs and initiatives by entities such as the World Health Organization (WHO) and UNICEF, parents and healthcare providers are more informed on the essential role of vaccines in preventing childhood diseases, ultimately boosting demand for advanced pediatric vaccines. 

• Government and Non-Governmental Funding in Vaccine R&D: The surge in government and NGO funding for vaccine research and development has accelerated innovations in the pediatric vaccine sector. Programs like Gavi, the Vaccine Alliance, and government grants for research institutions are supporting new vaccine candidates. This financial backing is fostering faster clinical trials, enhancing vaccine accessibility, and enabling more pediatric-targeted advancements in immunization technologies. 

Inquire before buying. 

Restraints 

• High Cost of Immunization Programs: The cost of immunization, particularly for newer vaccines such as mRNA and combination vaccines, presents a significant barrier in low- and middle-income countries. Many governments and healthcare systems in these regions struggle to afford these higher-priced vaccines, which limits the scope of vaccination programs and reduces coverage rates for essential pediatric immunizations. 

• Limited Medical Coverage for Immunization: In low and middle-income countries, many families lack adequate medical insurance or social safety nets that cover vaccination costs. Without subsidized programs or insurance coverage, out-of-pocket expenses for immunization become prohibitive for low-income households, which hinders widespread vaccine uptake and leaves vulnerable children at greater risk for preventable diseases. 

• Insufficient Healthcare Infrastructure and Services: Limited healthcare infrastructure, including a shortage of clinics, trained healthcare providers, and cold chain logistics, further impedes vaccine distribution and administration. In many remote and underserved regions, these limitations lead to inconsistent vaccine availability, logistical challenges in delivery, and lower immunization rates, which undermine public health efforts in these areas. 

Personalize this research. 

Hotspot 

Explore purchase options. 

Table of Contents 

1.       Introduction         1.1.    Research Methodology         1.2.    Scope of the Study  2.       Market Overview / Executive Summary         2.1.    Global Pediatric Vaccine Market (2019 – 2023)         2.2.    Global Pediatric Vaccine Market (2024 – 2030)  3.       Market Segmentation         3.1.    Global Pediatric Vaccine Market by Vaccine Type                3.1.1.    Monovalent                3.1.2.    Multivalent         3.2.    Global Pediatric Vaccine Market by Application                3.2.1.    Pneumococcal Disease                3.2.2.    Influenza                3.2.3.    Measles, Mumps and Rubella                3.2.4.    Others   4.       Regional Segmentation         4.1.    North America                4.1.1.    The US                4.1.2.    Canada                4.1.3.    Mexico         4.2.    South America                4.2.1.    Brazil                4.2.2.    Argentina                4.2.3.    Colombia                4.2.4.    Rest of South America         4.3.    Asia Pacific                4.3.1.    China                4.3.2.    India                4.3.3.    Japan                4.3.4.    South Korea                4.3.5.    Rest of Asia Pacific         4.4.    Europe                4.4.1.    The UK                 4.4.2.    Germany                4.4.3.    Belgium                4.4.4.    France                4.4.5.    Rest of Europe         4.5.    The Middle East                4.5.1.    Turkey                4.5.2.    UAE                4.5.3.    Saudi Arabia                4.5.4.    Rest of the Middle East         4.6.    Africa                4.6.1.    Egypt                4.6.2.    South Africa                4.6.3.    Rest of Africa  5.       Value Chain Analysis of the Global Pediatric Vaccine Market  6.       Porter Five Forces Analysis         6.1.    Threats of New Entrants         6.2.    Threats of Substitutes         6.3.    Bargaining Power of Buyers         6.4.    Bargaining Power of Suppliers         6.5.    Competition in the Industry  7.       Trends, Drivers and Challenges Analysis         7.1.    Market Trends         7.1.1.    Market Trend 1         7.1.2.    Market Trend 2         7.1.3.    Market Trend 3         7.2.    Market Drivers         7.2.1.    Market Driver 1         7.2.2.    Market Driver 2         7.2.3.    Market Driver 3         7.3.    Market Challenges         7.3.1.    Market Challenge 1         7.3.2.    Market Challenge 2         7.3.3.    Market Challenge 3  8.       Opportunities Analysis         8.1.    Market Opportunity 1         8.2.    Market Opportunity 2         8.3.    Market Opportunity 3  9.       Competitive Landscape         9.1.    Sanofi          9.2.    Merck & Co., Inc.         9.3.    Pfizer Inc.         9.4.    Sinovac Biotech Ltd.          9.5.    AstraZeneca Plc         9.6.    Company 6         9.7.    Company 7         9.8.    Company 8         9.9.    Company 9         9.10.  Company 10

Know the research methodology. 

Pediatric Vaccine Market – FAQs 

1.  What is the current size of the pediatric vaccine market? 

Ans. In 2025, the pediatric vaccine market size is USD 23,667.31 Mn. 

2.  Who are the major vendors in the pediatric vaccine market?  

Ans. The major vendors in the pediatric vaccine market are Sanofi; Merck & Co., Inc.; Pfizer Inc.; Sinovac Biotech Ltd.; AstraZeneca Plc. 

3.  Which segments are covered under the pediatric vaccine market segments analysis?  

Ans. The pediatric vaccine market report offers in-depth insights into Vaccine Type, Application, and Geography.